Evidence map›Paper›PMID 40600499›Full record

Observational studyJournal of the International AIDS Society2025

User and healthcare provider early experiences with the PrEP ring: a quantitative study on the introduction of a new PrEP method in Eswatini.

Anita Hettema, Siphesihle Shongwe, Haley Sisel, Mxolisi Khumalo, Ncediso Gama, Nolwazi Khanyile, Buyile Mahlalela, Sindy Nana Matse, Jill M Peterson

Registry-linked trialAbstract readMulticenter StudyObservational Study
In one paragraph

Observational study in Journal of the International AIDS Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05889533 (Increasing PrEP Options for Women in Eswatini), which is not on this map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05889533 terminatednot on this map

Increasing PrEP Options for Women in Eswatini: A Prospective Mixed Methods Study on the Introduction of the PrEP Vaginal Ring

Typeobservational_patient_registrySponsorFHI 360Ran2023 to 2025Enrolled904ConditionsHIV Prevention
3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Anita HettemaFHI 360, Mbabane, Eswatini.ORCID https://orcid.org/0000-0002-9764-2178
Siphesihle ShongweFHI 360, Mbabane, Eswatini.
Haley SiselFHI 360, Durham, North Carolina, USA.
Mxolisi KhumaloFHI 360, Mbabane, Eswatini.
Ncediso GamaFHI 360, Mbabane, Eswatini.
Nolwazi KhanyileFHI 360, Mbabane, Eswatini.
Buyile MahlalelaFHI 360, Mbabane, Eswatini.
Sindy Nana MatseMinistry of Health, Mbabane, Eswatini.
Jill M PetersonFHI 360, Durham, North Carolina, USA.ORCID https://orcid.org/0000-0002-7075-3003

Funding

United States Agency for International Development 7200AA21CA00011
6 · The paper itself

Abstract

introductionEswatini prepared for the national rollout of HIV pre-exposure prophylaxis (PrEP) choice through a mixed-method demonstration study introducing the PrEP dapivirine vaginal ring in 12 Ministry of Health-supported sites. The Eswatini PrEP Ring Study aimed to describe user preferences for, and experiences with, the PrEP ring, and provider impressions. The objective was to provide real-world data on client preferences and experiences related to PrEP choice, and healthcare provider perspectives on the feasibility and acceptability of offering PrEP choice. A subset of quantitative findings is presented here.

methodsDuring May 2023-August 2024, 12 study sites in Eswatini began offering a choice between the PrEP ring and oral PrEP to women 18 years and older who were HIV negative, not pregnant or breastfeeding, and interested in PrEP. Current oral PrEP users who were satisfied with the method were not recruited. Users' early experiences with the PrEP ring were assessed through structured enrolment and follow-up questionnaires. Factors associated with choosing the PrEP ring at enrolment were assessed using logistic regression. During the first 2 months of offering PrEP choice, providers (n = 16) completed a structured questionnaire on the feasibility and acceptability of PrEP choice service delivery. CLINICAL TRIAL NUMBER: NCT05889533

resultsAt enrolment, 69% (n = 625/904) chose the PrEP ring. Predictors for choosing the ring included ages 25+ (25-34 years AOR = 1.44, 95% CI [1.03, 2.02]; ages 35+ years AOR = 1.69, 95% CI [1.07, 2.68]), higher education (AOR = 1.71 for some/completed high school, 95% CI [1.20, 2.43]; AOR = 1.87 for vocational/tertiary education, 95% CI [1.21, 2.90]) and using either longer-acting (AOR = 2.23, 95% CI [1.28, 3.89]) or shorter-acting contraceptives (AOR = 1.63, 95% CI [1.14, 2.32]) versus no modern family planning method. Participants reported high levels of ease and confidence (98%) in using the ring. Ninety-four percent of PrEP counsellors (n = 8) and nurses (n = 8) felt prepared to offer PrEP choice and liked choice counselling but had concerns about clients' ability to return on time for refills of either method.

conclusionsMany women in Eswatini were willing to try the PrEP ring. Providers were enthusiastic about counselling on PrEP choice and introducing women to the ring.

Indexed as

Anti-HIV AgentsContraceptive Devices, FemaleHealth PersonnelHIV InfectionsPatient Acceptance of Health CarePre-Exposure ProphylaxisAdolescentAdultEswatiniFemaleHumansMaleMiddle AgedPyrimidinesSurveys and QuestionnairesYoung AdultAnti-HIV AgentsDapivirinePyrimidinesdapivirine vaginal ringEswatinihealthcare providerHIV preventionPrEP choicewomen

Identifiers

PMID40600499
PMCPMC12215817

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.